Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 434.45M P/E - EPS this Y 88.30% Ern Qtrly Grth -
Income -267.63M Forward P/E -7.74 EPS next Y 25.70% 50D Avg Chg -
Sales 1.82M PEG - EPS past 5Y - 200D Avg Chg 32.00%
Dividend N/A Price/Book 7.28 EPS next 5Y - 52W High Chg -50.00%
Recommedations 2.30 Quick Ratio 1.57 Shares Outstanding 21.62M 52W Low Chg 212.00%
Insider Own 17.22% ROA -11.06% Shares Float 16.67M Beta 1.95
Inst Own 26.21% ROE -195.43% Shares Shorted/Prior 378.14K/391.12K Price 19.51
Gross Margin 100.00% Profit Margin - Avg. Volume 76,410 Target Price 23.00
Oper. Margin -1,459.02% Earnings Date May 9 Volume 46,738 Change -3.70%
About Cibus, Inc.

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

Cibus, Inc. News
04/25/24 Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
03/23/24 Cibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
03/21/24 Cibus Reports Fourth Quarter Financial Results and Provides Business Update
03/19/24 Cibus Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024
03/13/24 Cibus to Participate in the 36th Annual Roth Conference
03/07/24 Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call
02/26/24 Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US
02/07/24 European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques
01/25/24 European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques
01/17/24 Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales
01/09/24 Cibus Announces Major Breakthrough in Wheat Regeneration from Single Cells
01/04/24 Cibus Enters into a Latin America Collaboration Agreement with Interoc to deliver rice growers an innovative rice weed control system
12/16/23 Co-Founder of Cibus Picks Up 23% More Stock
12/12/23 Cibus Announces $20.3 Million Registered Direct Offering
12/01/23 European Union Notifies Trading Partners on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques
11/30/23 Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus
11/09/23 Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update
11/06/23 European Parliament Releases Draft Report on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques
03:05 PM Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call
09/18/23 Jim Collins to Join Cibus Board of Directors
CBUS Chatroom

User Image xbizo Posted - 04/29/24

@Waldairz $CBUS already has an active shelf offering. They had to start selling into the market by about now to avoid BK, so I would guess at this dilution for the drop in share price.

User Image Stock_Titan Posted - 04/25/24

$CBUS Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call https://www.stocktitan.net/news/CBUS/cibus-to-report-first-quarter-2024-financial-results-on-may-9-2024-yf9khcxf7mg2.html

User Image Waldairz Posted - 04/18/24

$CBUS Cibus recently added a Sustainable Ingredients products Link to its website (I don’t remember the link being there). This is a very interesting move at this time as Rory indicated the Soy platform would be ready by end of Q2.

User Image Fullratio Posted - 04/15/24

Consumer Defensive sector stocks with high gross profit growth in Q4 2023 (TTM): $CBUS $LSF $LMNR

User Image Waldairz Posted - 04/09/24

$CBUS gotta think they will raise money and have positive announcement on soy before conference call.

User Image Fullratio Posted - 03/31/24

Consumer Defensive sector stocks with high revenue growth in Q4 2023 (TTM): $CBUS $ELF $CELH

User Image Waldairz Posted - 03/31/24

$CBUS Soy opens up 250m Acres and the sustainable ingredients industry. “Toughest Project in Biology”. The royalty/sales $ impact is not in any of their forecasts. Giddy up!

User Image Doozio Posted - 03/30/24

$CBUS chop chop a SEED is planted then da huckleberries grow into 🧠⏰. How far can Roger run?

User Image Microcap777 Posted - 03/28/24

$CBUS This is a crazy, thinly traded stock. I sold my remaining shares from 21.50 to 22.50. Been here since the Calyxt days, which was ALSO a nutty stock. I made 30 grand on it and then lost 10 grand on it. All in all, I have decent feelings about this one and will continue to watch it. It can move $5 in a HEARTBEAT. Lots of potential but they WILL need to raise capital before the revenue comes in. The insiders, though, do not seem to be selling which counts for a lot. If this falls back to the $16 area, I'll look to be back. Good luck all.

User Image Waldairz Posted - 03/26/24

$CBUS if this hits $30 it is going to $100. Sounds crazy but very possible.

User Image Waldairz Posted - 03/24/24

$CBUS $1B of royalty potential! This excludes sustainable ingredients. The is the next giant!

User Image Waldairz Posted - 03/22/24

$CBUS the single most important opportunity is soy. This opportunity greatly exceeds any opportunity in plant traits. The company could become a behemoth if they can prove viability of soy platform. They have P&G working with them so that is enough for me to believe they will build a viable platform.

User Image DonCorleone77 Posted - 03/21/24

$CBUS 2 of 2 - Cibus reports Q4 EPS ($12.59), consensus ($1.43) ....We've made significant progress on the commercial front with several advancements of these developed traits, including transfers to customers. We also continued the progression of our advanced traits - Sclerotinia resistance, and our HT2 trait in Canola and Winter Oilseed Rape - and our efforts to extend our proprietary RTDS platform to the world's major crops. Furthermore, we celebrated a key catalyst for our industry in February when the EU Parliament voted to advance new regulations that, when adopted, will treat the applications of gene editing technology like ours in a similar fashion as conventional hybridization techniques that have been in existence for centuries. This vote was a significant milestone for our entire industry and is a crucial step that will help Cibus usher in the gene editing era."

User Image DonCorleone77 Posted - 03/21/24

$CBUS 1 of 2 - Cibus reports Q4 EPS ($12.59), consensus ($1.43) Reports Q4 revenue $1.1M, consensus $380,000. The increase of $9.66 in net loss per share of Class A common stock is primarily driven by the non-cash goodwill and intangible assets impairment which accounted for approximately $11.32 in net loss per share of Class A common stock. This is partially offset by a year-over-year increase in weighted average shares outstanding. "2023 was a pivotal year for Cibus, both in terms of our evolution as a public company following the merger with Calyxt and the implementation of our commercial strategy as we transformed from our research and development origins," stated Rory Riggs, Co-Founder, Chairman, and CEO of Cibus. "The centerpiece of our commercialization goals are the commercial advancement of each of our three developed traits - Pod Shatter Reduction in Canola, and our two herbicide tolerance traits in Rice, HT1 and HT3....

User Image Stock_Titan Posted - 03/21/24

$CBUS Cibus Reports Fourth Quarter Financial Results and Provides Business Update https://www.stocktitan.net/news/CBUS/cibus-reports-fourth-quarter-financial-results-and-provides-business-2rckntf80kn6.html

User Image Mvc9111 Posted - 03/19/24

$BHIL Acquired by $ADM $CBUS

User Image Waldairz Posted - 03/15/24

$CBUS there’s something happening here but what it is ain’t exactly clear

User Image Stock_Titan Posted - 03/13/24

$CBUS Cibus to Participate in the 36th Annual Roth Conference https://www.stocktitan.net/news/CBUS/cibus-to-participate-in-the-36th-annual-roth-vzpcgm10xann.html

User Image Stock_Titan Posted - 03/07/24

$CBUS Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call https://www.stocktitan.net/news/CBUS/cibus-to-report-fourth-quarter-2023-financial-results-on-march-21-eccoz7bdkj3l.html

User Image Waldairz Posted - 03/04/24

$CBUS a lot of collaboration agreements but no sales. Waiting patiently.

User Image Germaneer Posted - 03/04/24

$CBUS

User Image TickerDD_com Posted - 02/26/24

From 2/23/2024, looking back across 22 Month-Ends for CBUS, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had More Positives (95%) $CBUS #CBUS #CBUSStock #TickerDD #CBUSPrice https://www.youtube.com/watch?v=aKdg4wboakE

User Image Stock_Titan Posted - 02/26/24

$CBUS Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US https://www.stocktitan.net/news/CBUS/cibus-and-loveland-products-collaborate-to-develop-and-sell-rice-62scdjd2i055.html

User Image Waldairz Posted - 02/14/24

$CBUS how much more development before Cbus can go to market

User Image Stock_Titan Posted - 02/07/24

$CBUS European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques https://www.stocktitan.net/news/CBUS/european-parliament-votes-to-support-proposal-for-the-regulation-of-lqjboqt77guj.html

User Image VirmoMopire Posted - 01/30/24

$CBUS Keep an eye on this one. Could be something brewing. 🔍

User Image MarxistPoltergeist Posted - 01/25/24

$CBUS price drop on no news, no signiy volume, looks like a good opportunity to increase my position a bit.

User Image Waldairz Posted - 01/23/24

$CBUS range bound until they can show a sale.

User Image Stockchooser Posted - 01/19/24

$CBUS 🔥🚀⬆️

User Image briefingcom Posted - 01/17/24

$CBUS (+6.3%): Cibus Global announces that the company is moving forward in the next step of commercialization of its developed traits https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240117070709CBUS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Analyst Ratings
HC Wainwright & Co. Buy Mar 22, 24
HC Wainwright & Co. Buy Oct 9, 23